These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 14678234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interaction between cyclic GMP protein kinase and cyclic AMP may be diminished in stunned cardiac myocytes.
    Yan L, Patel KN, Zhang Q, Scholz PM, Weiss HR.
    Eur J Pharmacol; 2001 Aug 24; 426(1-2):11-9. PubMed ID: 11525765
    [Abstract] [Full Text] [Related]

  • 3. Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes.
    Engel S, Yan L, Weiss H, Scholz P.
    Eur J Pharmacol; 2001 Jun 01; 421(1):23-30. PubMed ID: 11408045
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. SERCA inhibition limits the functional effects of cyclic GMP in both control and hypertrophic cardiac myocytes.
    Zhang Q, Davidov T, Weiss HR, Scholz PM.
    Pharmacology; 2009 Jun 01; 83(4):223-30. PubMed ID: 19258738
    [Abstract] [Full Text] [Related]

  • 12. Relationship between decreased function and O2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels.
    Yan L, Gong GX, Tse J, Scholz PM, Weiss HR.
    Res Exp Med (Berl); 1998 Oct 01; 198(3):109-21. PubMed ID: 9820898
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
    Straznicka M, Gong G, Yan L, Scholz PM, Weiss HR.
    J Cardiovasc Pharmacol; 1999 Aug 01; 34(2):229-36. PubMed ID: 10445674
    [Abstract] [Full Text] [Related]

  • 17. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
    Gandhi A, Yan L, Scholz PM, Huang MW, Weiss HR.
    Nitric Oxide; 1999 Dec 01; 3(6):473-80. PubMed ID: 10637126
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nitric oxide and cGMP protein kinase activity in aged ventricular myocytes.
    Zhang Q, Molino B, Yan L, Haim T, Vaks Y, Scholz PM, Weiss HR.
    Am J Physiol Heart Circ Physiol; 2001 Dec 01; 281(6):H2304-9. PubMed ID: 11709396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.